Leiden University Medical Center

Futó vizsgálatok

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· 3. fázis· AbbVie· Forrás

• Még nem toboroz

  A Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3

  2026-526408-60-00· 2. fázis· Vico Therapeutics B.V.· Forrás

• Toboroz

  ALBUMINUS: Dose reduction of human albumin during large-volume paracentesis in patients with cirrhosis

  2026-526167-38-00· 4. fázis· Amsterdam UMC Stichting· Forrás

• Még nem toboroz

  A Study of Brenipatide in Participants With Major Depressive Disorder

  NCT07928245· 2. fázis· Eli Lilly and Company· Forrás

• Még nem toboroz

  AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery

  NCT07883551· Catharina Ziekenhuis Eindhoven· Forrás

• Még nem toboroz

  RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer

  NCT07808138· 2. fázis· The Netherlands Cancer Institute· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Még nem toboroz

  A study investigating whether it is possible to preserve the bladder in participants with bladder cancer by starting with the drugs enfortumab vedotin plus pembrolizumab, followed by further treatment of the bladder depending on the effect on the bladder tumor: FIDELIO

  2026-525965-29-00· 2. fázis· Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting· Forrás

• Még nem toboroz

  Telestroke Triage in Suspected Stroke Patients

  NCT07657117· Nyika D. Kruyt· Forrás

• Toboroz

  A clinical trial to learn about the effects of IEV407 when given alone or with endocrine therapy in people with advanced breast cancer

  2025-522707-26-00· 1. fázis· Novartis Pharma AG· Forrás

• Toboroz

  OVACURE-2

  2025-522659-24-00· 1/2. fázis· Leids Universitair Medisch Centrum (LUMC)· Forrás

• Még nem toboroz

  Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC

  NCT07663747· 2. fázis· The Netherlands Cancer Institute· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  2025-524335-39-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Még nem toboroz

  Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)

  NCT07682129· 2. fázis· Entrada Therapeutics, Inc.· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)

  2023-505575-69-01· 3. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (delpacibart zotadirsen) for the Treatment of DMD with Gene Mutations Amenable to Exon 44 Skipping

  2025-523087-20-00· 3. fázis· Avidity Biosciences Inc.· Forrás

• Toboroz

  ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

  NCT07673627· 2. fázis· argenx· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Prilenia· Forrás

• Toboroz

  Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

  NCT07636148· Mark C Burgmans, MD PhD· Forrás

• Még nem toboroz

  Cangrelor safety and pharmacodynamics in paediatric subjects with congenital heart disease

  2025-523109-14-00· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

  NCT07554339· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

  NCT07365319· 2/3. fázis· Eikon Therapeutics· Forrás

• Toboroz

  PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  2025-522883-34-00· 4. fázis· Universitair Medisch Centrum Groningen· Forrás

• Toboroz

  LUMC-BOB1-B7-TCR.1 in relapsed and refractory B-cell malignancies

  2024-515900-38-00· 1/2. fázis· Leids Universitair Medisch Centrum (LUMC)· Forrás

• Még nem toboroz

  PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer

  2025-523134-28-00· 2/3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Még nem toboroz

  Venous Resection in Patients Undergoing Pancreatic Surgery

  NCT07621029· Sahlgrenska University Hospital· Forrás

• Toboroz

  Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

  NCT07585890· University Medical Center Groningen· Forrás

• Meghívásos bevonás

  An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy

  NCT07573631· 2. fázis· BioMarin Pharmaceutical· Forrás

• Toboroz

  Low-Field MRI in Stroke Code Patients

  NCT07702968· Leiden University Medical Center· Forrás

• Toboroz

  PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF E-VIM VACCINE CVX1 WITH OR WITHOUT ICI IN THE TREATMENT OF SUBJECTS WITH MUSCLE INVASIVE BLADDER CANCER (MIBC) OR LOCALIZED OR LOCALLY ADVANCED RENAL CELL CANCER (RCC).

  2025-523781-25-00· 1. fázis· CimCure B.V.· Forrás

• Meghívásos bevonás

  A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

  NCT07338968· 3. fázis· Aura Biosciences· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions

  NCT07498738· Leiden University Medical Center· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

  NCT07161869· Erasmus Medical Center· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  NCT07288177· 2. fázis· Genmab· Forrás

• Toboroz

  IMCISION: Towards organ preservation and cure via ultra-short immunotherapy in advanced oral cancer. The IMCISION II trial, an investigator-initiated multicentre randomised phase 3 trial

  2025-522500-24-00· 3. fázis· Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting· Forrás

• Toboroz

  CO2MO

  2025-520913-29-00· 4. fázis· Leids Universitair Medisch Centrum (LUMC)· Forrás

• Toboroz

  ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

  NCT07284420· 2. fázis· argenx· Forrás

• Toboroz

  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  NCT07252739· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

  NCT07280585· 3. fázis· University of Cologne· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  NCT07155187· 2/3. fázis· AbbVie· Forrás

• Toboroz

  A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

  2024-515125-28-00· 2. fázis· Imbria Pharmaceuticals Inc.· Forrás

• Toboroz

  Randomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus Bevacizumab Alone in Metastatic Colorectal Cancer Patients

  2024-520356-24-00· 2. fázis· Delcath Systems Inc.· Forrás

• Toboroz

  A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

  NCT06996782· 1/2. fázis· AstraZeneca· Forrás

• Toboroz

  NO Re-excision MelanomA - NORMA 2

  NCT07530887· 3. fázis· Marieke Goodijk· Forrás

• Toboroz

  Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI-SAVE

  2024-514693-47-01· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis

  NCT07371572· 3. fázis· Sint Maartenskliniek· Forrás

Showing 50 of 271.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák18 toboroz
• Vastagbélrák13 toboroz
• Hasnyálmirigyrák10 toboroz
• Duchenne-izomdisztrófia9 toboroz
• Melanóma9 toboroz
• Petefészekrák7 toboroz
• Gyermekkori daganatok6 toboroz
• Gyomor- és nyelőcsőrák6 toboroz
• Hólyagrák6 toboroz
• Huntington-kór6 toboroz
• Myasthenia gravis6 toboroz
• Stroke (szélütés)6 toboroz
• Koszorúér-betegség5 toboroz
• Máj- és epeúti rák5 toboroz
• Pitvarfibrilláció5 toboroz
• Prosztatarák5 toboroz
• Akut mieloid leukémia (AML)4 toboroz
• Congenital heart disease4 toboroz
• Deep vein thrombosis and pulmonary embolism4 toboroz
• Méhnyakrák4 toboroz
• Mielóma multiplex4 toboroz
• Szarkóma4 toboroz
• Szívelégtelenség4 toboroz
• 1-es típusú cukorbetegség3 toboroz
• Aortic stenosis3 toboroz
• Crohn-betegség3 toboroz
• Fej-nyaki daganatok3 toboroz
• Hodgkin-limfóma3 toboroz
• Liver cirrhosis3 toboroz
• Méhtestrák3 toboroz
• ANCA-asszociált vasculitis2 toboroz
• Áttétes emlőrák2 toboroz
• Brain metastases2 toboroz
• Depresszió2 toboroz
• Hearing loss2 toboroz
• HIV-fertőzés2 toboroz
• Magas vérnyomás2 toboroz
• Pituitary tumours2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Vesedaganat2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Amiloidózis1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Bipoláris zavar1 toboroz
• Chronic spontaneous urticaria1 toboroz
• Cushing's syndrome1 toboroz
• Cytomegalovirus infection1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Endometriózis1 toboroz
• Female infertility1 toboroz
• Glioblasztóma1 toboroz
• Hemofília1 toboroz
• Hidradenitis suppurativa1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Hyperparathyroidism1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• IgA-nefropátia1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus vesebetegség1 toboroz
• Lupus (SLE)1 toboroz
• Meningioma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Migrén1 toboroz
• Mild cognitive impairment1 toboroz
• Osteoarthritis1 toboroz
• Parkinson-kór1 toboroz
• Pikkelysömör1 toboroz
• Policisztás vesebetegség1 toboroz
• Rheumatoid arthritis1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vascular dementia1 toboroz

Lezárt vizsgálatok

• Toboroz

  A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis

  2025-523127-21-00· 1. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Lezárult

  A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC

  2025-522867-13-00· 2. fázis· Merus B.V.· Forrás

• Visszavonták

  Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

  NCT07353957· 2. fázis· Genmab· Forrás

• Visszavonták

  PREcision meDICine in Treatment in CardioVascular Disease

  NCT07369141· Maastricht University Medical Center· Forrás

• Még nem toboroz

  Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG

  NCT07118449· 2. fázis· XyloCor Therapeutics, Inc.· Forrás

• Lezárult

  A Study With CIT-013 in RA Patients

  NCT06567470· 2. fázis· Citryll BV· Forrás

• Toboroz

  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06966401· 3. fázis· Neurocrine Biosciences· Forrás

• Toboroz

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  NCT06989112· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication

  NCT06629740· Kontigo Care AB· Forrás

• Lezárult

  A phase 1b-2 study of mitomycin-C / capecitabine chemoradiotherapy combined with ipilumimab and nivolumab or nivolumab monotherapy as bladder sparing curative treatment for muscle invasive bladder cancer: the CRIMI study

  2023-509460-19-00· 1/2. fázis· Amsterdam UMC· Forrás

• Lezárult

  THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)

  2024-516260-29-00· 3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Fut, nem toboroz

  A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

  NCT06602479· 2. fázis· AbbVie· Forrás

• Lezárult

  Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point of view. Tailoring of treatment is done by taking the presence of autoantibodies and the quick response to glucocorticoids and JAK inhibitors into account.

  2024-511530-12-01· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Lezárult

  Insomnia in Primary Care

  NCT06575998· Leiden University Medical Center· Forrás

• Lezárult

  FOCALFLEX (CE Mark) Study

  NCT06271967· Abbott Medical Devices· Forrás

• Lezárult

  LIBERAL Study

  2023-507823-52-00· 3. fázis· Academisch Ziekenhuis Leiden· Forrás

• Lezárult

  A Phase 1/2 Study of TAS3351 in Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutations

  NCT05765734· 1/2. fázis· Taiho Oncology Inc.· Forrás

• Lezárult

  Older Adults Exercising On Time

  NCT06613958· Leiden University Medical Center· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· 3. fázis· argenx· Forrás

• Lezárult

  A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis

  NCT06149520· 2. fázis· Bayer· Forrás

• Fut, nem toboroz

  A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy

  NCT06280209· 1/2. fázis· BioMarin Pharmaceutical· Forrás

• Lezárult

  SGM-T1: SGM-101 tumor targeted fluorescence endoscopy in rectal polyps with suspected T1 adenocarcinoma or high grade dysplasia

  NCT06280690· 2. fázis· Academisch Ziekenhuis Leiden· Forrás

• Lezárult

  A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of colorectal brain metastases.

  NCT04755920· 2. fázis· Academisch Ziekenhuis Leiden· Forrás

• Lezárult

  A phase I/II open label, multicenter study evaluating the feasibility, safety and efficacy of point-of-care manufactured antiBCMA CAR T cells (GLPG5301; BCMACP03) in subjects with relapsed/refractory Multiple Myeloma (RRMM)

  2022-500782-27-00· 1/2. fázis· Lakefront Biotherapeutics· Forrás

• Lezárult

  Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)

  NCT05774691· 4. fázis· St. Antonius Hospital· Forrás

• Lezárult

  Perfect Fit: Evaluation of a Virtual Coach for Smoking Cessation and Physical Activity

  NCT06095999· Leiden University Medical Center· Forrás

• Lezárult

  Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

  NCT05672199· 2. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

  NCT05644561· 3. fázis· Alexion Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

  NCT05740566· 3. fázis· Amgen· Forrás

• Lezárult

  The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

  NCT05263245· 2. fázis· dr. Tom van der Hulle· Forrás

• Lezárult

  Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis

  NCT05370885· 2. fázis· Vedanta Biosciences Inc.· Forrás

• Lezárult

  PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

  NCT05639751· 1. fázis· Prelude Therapeutics Incorporated· Forrás

• Lezárult

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  NCT05287113· 2. fázis· Incyte Biosciences International Sàrl· Forrás

• Lezárult

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· 2. fázis· Edgewise Therapeutics, Inc.· Forrás

• Lezárult

  FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1

  NCT05518071· 2. fázis· Leiden University Medical Center· Forrás

• Leállították

  A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

  NCT05171075· 3. fázis· Anthos Therapeutics, Inc.· Forrás

• Lezárult

  Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

  NCT05678218· Erasmus Medical Center· Forrás

• Leállították

  A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis

  NCT05314517· 2. fázis· Kinevant Sciences GmbH· Forrás

• Leállították

  Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)

  NCT04908956· 2. fázis· ETOP IBCSG Partners Foundation· Forrás

• Lezárult

  PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

  NCT05522257· Leiden University Medical Center· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

  NCT05263934· 3. fázis· GlaxoSmithKline· Forrás

• Fut, nem toboroz

  HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

  NCT05338970· 3. fázis· Daiichi Sankyo· Forrás

• Lezárult

  A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

  NCT05452239· 4. fázis· H. Lundbeck A/S· Forrás

• Lezárult

  Reversal of opioid-induced respiratory depression with opioid antagonists - a pharmacokinetic pharmacodynamic modeling study in opioid naïve individuals and chronic opioid users under real-life conditions

  2024-518041-16-00· 4. fázis· Leids Universitair Medisch Centrum (LUMC)· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

  NCT05358717· 2. fázis· Novartis Pharmaceuticals· Forrás

• Leállították

  A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

  NCT05269355· 2/3. fázis· PTC Therapeutics· Forrás

• Fut, nem toboroz

  IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

  NCT05155254· 3. fázis· IO Biotech· Forrás

• Leállították

  A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

  NCT05171049· 3. fázis· Anthos Therapeutics, Inc.· Forrás

Showing 50 of 104.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Stroke (szélütés)125 munka · 9 vizsgálat
• Szívelégtelenség108 munka · 8 vizsgálat
• Deep vein thrombosis and pulmonary embolism93 munka · 11 vizsgálat
• Melanóma86 munka · 20 vizsgálat
• Rheumatoid arthritis85 munka · 4 vizsgálat
• Pitvarfibrilláció68 munka · 6 vizsgálat
• Krónikus vesebetegség62 munka · 6 vizsgálat
• Vastagbélrák59 munka · 23 vizsgálat
• Szarkóma56 munka · 14 vizsgálat
• Spondylitis ankylopoetica (Bechterew-kór)54 munka · 1 vizsgálat
• Koszorúér-betegség54 munka · 13 vizsgálat
• Osteoarthritis51 munka · 1 vizsgálat
• Migrén44 munka · 4 vizsgálat
• Duchenne-izomdisztrófia37 munka · 15 vizsgálat
• Hasnyálmirigyrák34 munka · 16 vizsgálat
• Petefészekrák31 munka · 11 vizsgálat
• Huntington-kór31 munka · 9 vizsgálat
• Szisztémás szklerózis (szkleroderma)31 munka · 6 vizsgálat
• Aortic stenosis28 munka · 9 vizsgálat
• Méhtestrák27 munka · 5 vizsgálat
• 1-es típusú cukorbetegség23 munka · 6 vizsgálat
• Congenital heart disease23 munka · 4 vizsgálat
• Narcolepsy22 munka · 0 vizsgálat
• Méhnyakrák22 munka · 4 vizsgálat
• Insomnia18 munka · 2 vizsgálat
• Lupus (SLE)18 munka · 4 vizsgálat
• Aortic aneurysm18 munka · 0 vizsgálat
• Arthritis psoriatica16 munka · 0 vizsgálat
• Hipertrófiás kardiomiopátia16 munka · 1 vizsgálat
• Myasthenia gravis16 munka · 11 vizsgálat